Cytoxan (Cyclophosphamide) — Patient Information (United Kingdom)

Cytoxan is the brand name used for cyclophosphamide, a chemotherapy medicine that is also used in some autoimmune conditions. This page explains, in plain language, what cyclophosphamide does, how it works in the body, how it is used, and important safety and interaction considerations. It is intended to help you understand your treatment and prepare for discussions with your healthcare team.

What is Cytoxan (cyclophosphamide)?

Cyclophosphamide is a medicine that belongs to a group called alkylating agents. In simple terms, it damages DNA in rapidly dividing cells. Because many cancer cells (and some immune cells in autoimmune disease) divide quickly, cyclophosphamide can help control disease activity.

Cyclophosphamide is a prodrug: it is converted in the body into active substances that work against cells.

How cyclophosphamide works (mechanism of action)

After the medicine is activated in the liver, cyclophosphamide produces chemical compounds that:

• Alkylate DNA, interfering with DNA replication and cell division.
• Cause cross-linking of DNA strands, which can lead to cell death.
• Also affect rapidly dividing immune cells, which contributes to its immunosuppressive effect in certain autoimmune conditions.

Because the medicine can affect healthy cells too—especially those that divide quickly—monitoring and supportive care are important.

Pharmacokinetics: what happens to the medicine in the body?

Pharmacokinetics describes how the body absorbs, activates, distributes, metabolises, and clears cyclophosphamide. While individual results vary, the key features are:

• Activation in the liver: Cyclophosphamide is processed in the liver into active metabolites (and further metabolites). This activation is central to its effectiveness.
• Distribution: Metabolites can distribute through the body, reaching tissues affected by cancer or immune activity.
• Excretion: Metabolites are cleared mainly via the kidneys and leave the body in urine. This is one reason bladder protection measures (such as hydration and specific medication in some regimens) may be used.
• Metabolism variability: Liver function, other medicines, and genetic differences in metabolism can influence how cyclophosphamide behaves.

Your treatment team may check blood counts and sometimes liver and kidney function regularly because these influence both safety and dosing decisions.

Typical uses in the UK

Cyclophosphamide may be used for cancers and for certain autoimmune conditions. The exact choice of regimen depends on the diagnosis, stage of disease, overall health, and treatment goals.

Common cancer indications

Examples of cancers where cyclophosphamide may be used (often as part of combination chemotherapy) include:

• Some forms of lymphoma (e.g., non-Hodgkin lymphoma and Hodgkin lymphoma, depending on regimen)
• Leukaemia regimens in combination therapies
• Breast cancer in certain chemotherapy schedules
• Ovarian cancer (in particular combination regimens)
• Multiple myeloma regimens in some combinations
• Soft tissue or sarcomas in selected protocols
• Some solid tumours in specialist protocols

Autoimmune and immunological indications

In severe autoimmune diseases, cyclophosphamide may be used to calm an overactive immune system when other treatments are insufficient. It is used under close supervision because it can significantly reduce immune function.

Examples may include:

• Severe forms of vasculitis
• Selected cases of lupus with major organ involvement (specialist-guided)
• Some forms of interstitial lung disease or other severe immune-mediated conditions (case-dependent)

The decision to use cyclophosphamide is typically specialist-led and based on the balance between expected benefit and risks.

How and when it’s taken or given

Your exact schedule depends on the condition being treated and the specific regimen. Cyclophosphamide is sometimes given:

• Orally (tablets) on a daily or intermittent schedule, or
• By infusion (IV) in cycles (for example, at intervals such as every few weeks), sometimes with other medicines.

Timing with your routine

If cyclophosphamide is prescribed orally in your regimen, it is commonly taken at a consistent time each day. Many regimens use a cycle structure (e.g., treatment days followed by rest periods) to allow recovery of blood counts.

It is important to follow your healthcare team’s instructions precisely, including when to take supportive medicines.

Missed doses

If a dose is missed, do not double up unless your treatment team specifically advises you to. Because cyclophosphamide schedules are varied and closely monitored, contact your clinic for guidance.

Dosing: what determines the dose?

Cyclophosphamide dosing can vary widely depending on diagnosis and regimen. In many protocols the dose is based on:

• Body surface area (BSA) (often for IV dosing)
• Height and weight
• Kidney and liver function
• Blood counts (to reduce the risk of severe low counts)
• Combination therapy (other medicines may affect cyclophosphamide handling)
• Age and overall fitness

Doses may be adjusted during treatment if blood counts drop, if side effects occur, or if organs such as the liver or kidneys are affected. Your team may also consider fertility preservation and bladder protection measures.

Food interactions: what to know

Food effects depend partly on the specific formulation and regimen. In general, cyclophosphamide can be taken with or without food in many cases, but it is safest to follow the instructions given for your particular pack and regimen.

• Try to be consistent: If your clinician or pharmacist advises a way to take it (with food or on an empty stomach), follow that advice each time.
• Grapefruit and herbal products: Avoid starting new herbal supplements or high-dose products without checking, as some may affect metabolism.
• Nausea management: If nausea occurs, eating small bland meals may help—discuss anti-sickness medicines if needed.

Alcohol and medicine interactions

Alcohol use during cyclophosphamide treatment should be discussed with your healthcare team. Both alcohol and cyclophosphamide can affect the liver and overall wellbeing, and alcohol may worsen side effects such as nausea, fatigue, and dehydration.

Alcohol

• Safer approach: Many patients are advised to limit or avoid alcohol during chemotherapy or severe immune suppression.
• Hydration is important: Dehydration can increase the risk of urine-related side effects. Alcohol can contribute to dehydration.

Other medicines (important interaction themes)

Cyclophosphamide has interactions based on liver metabolism and immune effects. Always tell your healthcare team about:

• Medicines that affect the liver enzymes (some antifungals, antibiotics, antivirals, and anticonvulsants can influence levels)
• Other medicines that suppress bone marrow (increases risk of severe low blood counts)
• Blood thinners (interaction risk depends on the specific anticoagulant and your clotting status)
• Vaccines (live vaccines may be unsafe during immunosuppression)
• Herbal supplements (e.g., high-dose St John’s wort is a known enzyme inducer; use should be avoided unless cleared by your team)

Your pharmacist can provide a medicines check-up before treatment begins and can alert you to any specific conflicts.

Safety profile: key risks and what monitoring is usually done

Cyclophosphamide is an effective medicine, but it has potential risks. Many side effects are manageable with prompt treatment, careful blood monitoring, and supportive measures.

Common and expected side effects

• Nausea and vomiting (anti-sickness medicines are often provided)
• Fatigue
• Hair thinning or hair loss (may be partial or complete depending on regimen)
• Reduced appetite
• Changes in blood counts (white cells, red cells, and platelets)

Serious risks to watch for

• Infection risk from low white blood cells (neutropenia): contact your healthcare team urgently if you develop a fever or signs of infection.
• Bleeding risk from low platelets (thrombocytopenia): seek advice if you have unusual bruising, bleeding gums, nosebleeds, or blood in urine/stool.
• Bladder/urinary tract irritation (haemorrhagic cystitis): cyclophosphamide metabolites can irritate the bladder. Hydration and bladder-protecting medicines are used in some treatment plans.
• Fertility effects: cyclophosphamide can affect fertility in both men and women. Fertility preservation options may be discussed before starting treatment.
• Secondary cancers: there is a small long-term risk of secondary malignancies with chemotherapy exposure.
• Heart and lung effects: depending on dose and other treatments, specialist monitoring may be needed. Report breathlessness, chest pain, or persistent cough promptly.

Pregnancy and breastfeeding

Cyclophosphamide can harm an unborn baby. It is important to discuss contraception, pregnancy planning, and breastfeeding plans with your clinical team. Many chemotherapy medicines require avoiding pregnancy during treatment and for a period after.

Allergy and infusion reactions (if given IV)

If you receive cyclophosphamide by infusion, allergic or infusion reactions can occur. Your healthcare setting will monitor you and treat reactions if they happen.

Practical use tips for patients

• Hydration: Follow the hydration advice provided with your regimen. This can help reduce bladder irritation risk.
• Blood tests: Attend all blood test appointments. Treatment may be delayed or dose-adjusted based on results.
• Report symptoms early: Fever, urinary burning/blood, severe breathlessness, uncontrolled vomiting, or sudden unusual bleeding should be reported promptly.
• Oral medicine handling: If taking tablets at home, follow safe handling guidance given by your team. Wear gloves if instructed (some centres provide specific instructions). Keep out of reach of children and pets.
• Oral care: Mouth ulcers or soreness can occur. Use gentle brushing, consider non-alcohol mouthwashes, and ask about preventive measures.
• Infection prevention: Avoid close contact with people who have contagious infections. Ask whether you should take any preventative medicines (e.g., anti-infective prophylaxis) during periods of low blood counts.
• Contraception: Use effective contraception as advised by your team throughout treatment and afterwards for the recommended timeframe.

Alternative options

Depending on the condition being treated, alternative medicines or strategies may include other chemotherapy agents, different immunosuppressants, targeted therapies, or supportive treatments. Your specialist selects an option based on: disease type, severity, previous treatments, expected benefits, and risk profile.

Examples of alternatives (not exhaustive) may include:

• For some cancers: other alkylating agents, taxanes, platinum-based therapies, anti-CD antibodies, or targeted treatments depending on the tumour type.
• For autoimmune disease: corticosteroids, mycophenolate mofetil, azathioprine, methotrexate, biologics, or other specialist immunosuppressants.
• Supportive medicines: anti-sickness medicines, growth factors for blood counts, and bladder protection strategies where appropriate.

Discuss your options with your treating clinician, especially if you are concerned about fertility, infections, or long-term risks.

UK market and legal/regulatory context (high-level)

In the United Kingdom, medicines such as cyclophosphamide are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). Cancer chemotherapy and immunosuppressant medicines are generally supplied under strict governance to ensure correct handling, appropriate safety monitoring, and safe administration.

Availability in the UK can depend on the specific product type (brand vs generic), supply chain status, and hospital pharmacy processes. Always follow the instructions and packaging provided with the medicine you receive.

Recent guidance and safety updates (what to look for)

Safety recommendations for chemotherapy commonly evolve through:

• Local oncology/haematology protocols (hospital-specific dosing and supportive care pathways)
• MHRA safety communications and updates on risk management
• Changes in national practice guidelines through bodies such as NICE and specialist societies
• Updates on vaccination timing and infection prevention during immunosuppression

Your clinic should inform you about any relevant updates for your regimen. If you want to check official information, rely on MHRA and your NHS team’s guidance.

Delivery and availability (online pharmacy information)

Availability of cyclophosphamide products may vary. If you are purchasing via an online pharmacy service, delivery options depend on stock, whether the product is being dispatched from a licensed UK pharmacy, and any cold-chain requirements (if applicable to other products you may buy).

For chemotherapy medicines, correct packaging, handling, and documentation are essential. Your supplier should provide:

• Clear product identification (strength, form, and batch details when relevant)
• Storage instructions
• How and when to take/use (matching your regimen)
• Customer support for urgent questions about administration or side effects

If you are unsure whether a product is suitable for your treatment schedule, ask before ordering.

FAQ

1) Is Cytoxan the same as cyclophosphamide?

Yes. Cytoxan is a brand name. The active ingredient is cyclophosphamide. Different brands and generic versions may exist, but they contain the same active medicine (the exact formulation can vary).

2) How long does cyclophosphamide take to work?

The onset of action depends on why it is being used and the regimen. In cancer treatment, responses can take weeks, and each cycle contributes to tumour control. In autoimmune disease, improvement may also take time, as the immune system adjusts. Your team will assess response using clinical review and sometimes scans or blood markers.

3) What should I do if I feel unwell during treatment?

Because cyclophosphamide can lower blood counts, it is important to get advice quickly. Contact your healthcare team urgently if you have: a fever, shaking chills, severe sore throat, signs of infection, unusual bleeding, or severe breathlessness.

4) Does cyclophosphamide affect blood tests?

Yes. It commonly lowers white blood cells and other blood components, which is why regular monitoring is part of most regimens. Treatment may be delayed or adjusted based on results.

5) Can I drive or operate machinery?

Many people can drive if they feel well, but treatment may cause fatigue, dizziness, or nausea. Avoid driving if you feel unwell or impaired. If you take anti-sickness medicines that cause drowsiness, follow the warnings on those products.

6) Are there restrictions on vaccinations?

Vaccination advice during immunosuppression varies by treatment intensity and timing. In general, live vaccines may be unsafe during chemotherapy. Ask your clinic or pharmacist what applies to your schedule.

7) Will cyclophosphamide cause hair loss?

Hair thinning or hair loss can occur with chemotherapy. The extent depends on the regimen and individual factors. If hair loss concerns you, ask about scalp cooling or wig/hair support services where available.

8) How can I reduce nausea?

Anti-sickness medicines are often prescribed as part of chemotherapy care. Taking them as directed is important. Small frequent meals, avoiding strong smells, and staying hydrated can help. If nausea is not controlled, contact your team promptly.

9) What about fertility preservation?

Cyclophosphamide can affect fertility. If you want children in the future, discuss fertility preservation options before starting treatment. These options may include freezing sperm or eggs or other strategies, depending on your circumstances.

10) When should I seek emergency help?

Seek emergency medical help or follow your local urgent guidance if you experience severe allergic reaction symptoms (e.g., swelling of face/lips, trouble breathing), signs of serious infection (especially fever), uncontrolled bleeding, or severe breathing difficulties.

Important reminder

This information is designed to support understanding and preparation. Your healthcare team’s advice is the most important reference for your specific regimen. If you have questions about your treatment plan, side effects, or interactions with other medicines you take, speak to your clinician or pharmacist.